Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
fda
2
×
life sciences
national blog main
acute hepatic porphyrias
akin akinc
alnylam pharmaceuticals
aminolevulinic acid
boston
boston blog main
boston top stories
cannabidiol
dravet syndrome
epidiolex
fen-phen
fenfluramine
givosiran
gw pharmaceuticals
lennox-gastaut syndrome
onpattro
patisiran
paul matteis
rna interference
san francisco
san francisco blog main
san francisco top stories
stifel financial
zogenix
What
ago
drug
fda
medicine
2
×
pharmaceuticals
weeks
2
×
alnylam
approval
approved
battle
cannabis
data
derivative
epilepsy
form
gw
gw’s
indicated
interference
marijuana
market
nod
quick
rare
rna
rnai
second
seek
sets
speedy
won’t
zogenix
Language
Current search:
weeks
×
medicine
×
fda
×
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug